1/9
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
delirium
acute
physiological cause
reversible
fluctuate
very sudden
dementia
slow onset
many causes
more apparent over time
big umbrella of progressive cognitive changes
alzheimers
severe memory loss interferes with ability to function
alzheimers stages
mild: able to function, memory lapses, word + thought loss, poor planning/organization
moderate: mood/personality changes, worse memory loss, disorientation, incontinence, sundowning, wandering
severe: unable to respond to environment, full time care, physical inabilities (passing soon)
cholinesterase inhibitors
prevent AcH breakdown to temporarily improve sx (in early stage)
n/v/d, live toxicity
NMDA receptor antagonist
blocks glutamate receptors
Leceanemab (Leqembi)
prevents amyloid plaques
serious SE: brain swelling or bleeding
Donanemab (Kisunia)
works better but more risks
also targets amyloid plaques by teaching immune system to remove
potentially life threatening: brain swelling and bleeding (3 deaths)
therapeutic interventions
reorientation
repetition
maintain safety
ADL’s
movement (fall risk)
patience
distraction
personalization
CO end of life options act
18
terminal w/ less than 6 months
15 day period between acceptance and prescription ordered (many people die in)